Clinical milestones keep shifting, but your financial model still reflects the original plan
You're managing grants, equity, and subsidies at once, with no unified view of your runway
Regulatory delays are burning cash you hadn't budgeted for
Your investor reporting reads like a science update, not a financial case
Your finance setup was built for a pre-clinical team. It won't carry you through commercialization.
